Melanotan II Dosage Guide

What Is the Standard Melanotan II Dosage Range?

Melanotan II dosing in research and user reports follows a relatively consistent protocol, though individual variation exists. The standard dosage begins at a test dose to assess individual tolerance and response, followed by a loading phase, and finally a maintenance phase.

Initial test dose: 0.1-0.25 mg (100-250 mcg) injected subcutaneously once to evaluate personal tolerance. This is essential because side effect sensitivity varies dramatically between individuals. Some users experience minimal nausea at standard doses while others are highly sensitive.

Loading phase dosage: 0.25-0.5 mg (250-500 mcg) injected every other day for 2-4 weeks. This phase builds up the compound in your system and initiates visible tanning effects. Most users report noticeable darkening within 7-14 days of loading phase initiation.

Maintenance dosage: 0.25-0.5 mg administered 1-3 times weekly to sustain the developed tan. Frequency depends on desired tan intensity and individual fading rate. Most users report maintenance injections every 5-7 days maintain optimal coloration.

How Does Cycle Length Affect Results?

Cycle duration directly impacts the depth and duration of tanning effects. Melanotan II does not create a permanent tan — it stimulates melanin production that eventually degrades and is shed with normal skin cell turnover.

A 2-week loading cycle produces noticeable but moderate tanning. Users report 1-2 shade increases compared to baseline. This short cycle works for individuals testing tolerance or seeking subtle enhancement.

A 3-4 week loading cycle produces more dramatic tanning, with reports of 2-3 shade increases and visible effects on lips, nipples, and other areas with higher melanocyte density. This is the most commonly reported cycle duration in user data.

Post-cycle tan duration after completing a loading phase: 4-8 weeks to fade completely without maintenance injections. Tan darkens during the first 1-2 weeks post-injection due to continued melanin synthesis, then gradually fades. UV exposure or tanning bed use during fading phase can extend tan duration significantly.

What Are Dosage Protocols for Specific Goals?

How Should Dosage Be Adjusted Based on Body Weight?

Body weight significantly influences optimal Melanotan II dosing. The compound distributes throughout total body water and lipid compartments, meaning heavier individuals may require proportionally higher doses for equivalent effects.

General guideline: approximately 3-5 mcg per kilogram of body weight. A 80 kg (176 lb) individual would target 240-400 mcg per dose, while a 100 kg (220 lb) individual would target 300-500 mcg. Individuals under 60 kg should typically start at the lower end of dosing ranges.

However, individual variation in receptor sensitivity, metabolism, and melanocyte density overrides weight-based calculations. Start at lower doses regardless of weight and titrate upward based on response and tolerability.

What Is the Optimal Injection Timing and Frequency?

Injection timing during the loading phase affects side effect intensity and tanning results. Every-other-day injection timing (e.g., Monday, Wednesday, Friday) allows 24-36 hours between doses, balancing steady-state drug concentration with partial clearance.

Daily injections produce more consistent drug levels but increase nausea risk. Every-other-day injections report lower nausea incidence while maintaining effective tanning stimulus.

Time of day consideration: Some users report less nausea when injecting before sleep, allowing tolerance to develop during rest. Others inject in the morning and stay hydrated throughout the day. Consistency matters more than specific timing.

During maintenance phase, reducing frequency to 2-3 times weekly (e.g., Monday, Wednesday, Friday) maintains tan while minimizing total compound exposure and potential long-term receptor downregulation.

How Should Dosage Be Adjusted for Nausea or Side Effects?

If nausea becomes intolerable during loading phase, reduce dose by 25-50% and increase frequency slightly to maintain total weekly compound exposure. For example, reduce from 0.5 mg every other day to 0.25 mg daily.

If nausea persists at lower doses, pause for 2-3 days to allow compound clearance, then resume at 50% of previous dose with slower titration (every 3-4 days increase by 50 mcg rather than jumping to target dose).

Incorporate anti-nausea strategies: injecting before sleep, taking with light food, ginger supplementation, staying hydrated, and avoiding alcohol. Many users develop nausea tolerance within 1-2 weeks despite dose being unchanged.

If blood pressure elevation, involuntary erections, or yawning becomes problematic, reduce dose and increase injection intervals. These effects typically resolve within hours to days as the body adapts.

What Are Reconstitution Dose Considerations?

Melanotan II is supplied as a lyophilized (freeze-dried) powder requiring reconstitution with bacteriostatic water. Standard vials contain 10 mg of powder. Reconstitution volume determines final concentration and dosing accuracy.

10 mg reconstituted in 10 mL bacteriostatic water produces 1 mg/mL concentration. This allows 0.25-0.5 mg doses via small 0.25-0.5 mL injections, which is practical and measurable.

Reconstitution in 5 mL produces 2 mg/mL concentration, requiring 0.125-0.25 mL injections. This is more concentrated but creates measuring difficulty with standard insulin syringes (which measure in mL with 0.5 mL graduations).

Use sterile, pharmaceutical-grade bacteriostatic water (0.9% benzyl alcohol content). Reconstituted solution is stable for 30 days at room temperature or 60+ days refrigerated. Always use sterile technique during reconstitution and storage to prevent bacterial contamination.

How Does Individual Metabolism Affect Dosing?

Melanotan II metabolism varies substantially between individuals based on genetics, liver function, gut microbiota composition, and overall metabolic health. This explains why some users report visible effects at 0.25 mg while others require 0.5+ mg for equivalent response.

Individuals with slower metabolism may develop nausea more readily at standard doses and benefit from longer dosing intervals or lower doses. Those with faster metabolism may require higher doses to achieve visible effects.

Factors that may slow MT-II metabolism: older age, liver dysfunction, certain medications (antifungals, protease inhibitors), obesity, and low metabolic rate. Conversely, younger age, athletic individuals, and those with high metabolic rates typically clear MT-II faster.

Assess personal metabolism during the test dose phase. If test dose effects are very pronounced, expect to use lower maintenance doses. If test dose effects are minimal, anticipate needing higher doses than population average.

What Are Dosage Interactions with Other Compounds?

Melanotan II should not be stacked with other melanocortin receptor agonists (PT-141, Melanotan I). Redundant receptor activation increases side effects without additional benefit.

Combination with growth hormone secretagogues (ipamorelin, CJC-1295): no direct pharmacokinetic interaction, but combined nausea and appetite suppression from both compounds can be significant. Consider reducing doses of both.

Combination with tanning beds or UV exposure: enhances tanning effects significantly but increases UV-related skin damage. Use sunscreen SPF 15-30 after sessions to reduce photo-damage while preserving tanning stimulus.

Alcohol consumption: no direct pharmacokinetic interaction with Melanotan II, but alcohol increases dehydration and nausea risk during loading phase. Avoid alcohol during early dosing days.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

FAQ: Melanotan II Dosage